Table 2 Clinical and biological characteristics of the non-SVR and SVR groups

Age, years^a

69 (21–85)

72 (57–87)

Gender (male/female)

46/18

23/7

Plt (×10³/μl)^a

14.2 (3.1–31.0)

12.7 (7.2–34.6)

BMI (kg/m²)^a

21.5 (18.5–33.5)

22.5 (18.9–30.2)

Alb (g/dl)^a

4.1 (2.8–5.1)

4.1 (3.0–4.9)

T-Bil (mg/dl)^a

0.7 (0.3–2.9)

0.8 (0.3–2.7)

AST (U/L)^a

36.5 (14–114)

33.5 (13–66)

ALT (U/L)^a

30.9 (9–114)

25.5 (11–45)

M2BPGi (COI)^a

2.79 (0.29–8.75)

2.37 (0.42–8.60)

FIB-4 index^a

4.27 (0.34–13.7)

3.48 (1.19–6.33)

Fibrosis (F:0–1/2/3/4)

(1/21/29/13)

(1/15/10/4)

Inflammation (A:0/1/2/3)

(0/7/42/15)

(0/5/12/13)

FibroScan (kPa)^a

13.9 (2.5–46.4)

11.9 (5.6–46.4)

VTQ (m/s)^a

1.69 (0.95–3.28)

1.81 (0.89–3.45)

HCC Stage (I/II/III)

(30/25/9)

(18/10/2)